SCHEMBL12489409

SCHEMBL12489409

CC(C)(C)N(C1CCN(c2cccc(-n3ccnn3)c2)C1)[N+]([O-])=NO

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 11/20 0.40
▸ KEAP1 Q14145 1/20 0.37
▸ HCRTR1 O43613 2/20 0.32
▸ HCRTR2 O43614 2/20 0.32
▸ PRKCQ Q04759 1/20 0.31
▸ SLC6A2 P23975 1/20 0.30
▸ SLC6A4 P31645 1/20 0.30
▸ SLC6A3 Q01959 1/20 0.30
▸ CSNK2A2 P19784 1/20 0.30
▸ MAPK8 P45983 1/20 0.30
▸ MAPK10 P53779 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15362509 0.77 NOTUM (0.38) NOTUMKEAP1HCRTR1HCRTR2PRKCQ
SCHEMBL12166225 0.72 NOTUM (0.38) NOTUMKEAP1HCRTR1HCRTR2PRKCQ
SCHEMBL12099625 0.71 NOTUM (0.51) NOTUMKEAP1HCRTR1HCRTR2SLC6A2
SCHEMBL12166207 0.70 NOTUM (0.40) NOTUMKEAP1HCRTR1HCRTR2PRKCQ
SCHEMBL12524335 0.69 NOTUM (0.45) NOTUMKEAP1HCRTR1HCRTR2PRKCQ
SCHEMBL19011688 0.68 NOTUM (0.44) NOTUMKEAP1HCRTR1HCRTR2PRKCQ
SCHEMBL12099603 0.68 NOTUM (0.46) NOTUMKEAP1HCRTR1HCRTR2PRKCQ
SCHEMBL14961974 0.66 NOTUM (0.75) NOTUMKEAP1
SCHEMBL15362507 0.65 KMT2A (0.34) HCRTR1HCRTR2
SCHEMBL18726009 0.64 NOTUM (0.55) NOTUMKEAP1HCRTR1HCRTR2MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2683687-A1 PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES Merck Sharp & Dohme Corp. (US) 2014-01-15 — — EP disclosed
WO-2012122077-A1 PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-09-13 — — WO disclosed
Send feedback